![Kenneth Ferguson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Ferguson
Private Equity Investor bei
Accelerator Services Corp
Profil
Kenneth M.
Ferguson's career history includes current and former positions as well as education.
Currently, Dr. Ferguson is an Operating Partner at Accelerator Services Corp.
In the past, he held positions such as President, Chief Executive Officer & Director at Vactx International, Inc. from 2008 to 2010, COO, Chief Scientific Officer & Director at Lilly ICOS LLC, and Independent Director at Cyclacel Pharmaceuticals, Inc. from 2022 to 2025.
He also served as President at ICOS Corp.
from 1990 to 2007 and as Chief Development Officer & Vice President at Omeros Corp.
from 2010 to 2017.
Additionally, Dr. Ferguson worked as the Chief Scientific Officer at EMulate Therapeutics, Inc. Dr. Ferguson obtained an undergraduate degree from Cornell University and a doctorate degree from Texas University of Health Center at San Antonio.
Aktive Positionen von Kenneth Ferguson
| Unternehmen | Position | Beginn |
|---|---|---|
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Kenneth Ferguson
| Unternehmen | Position | Ende |
|---|---|---|
| BIO GREEN MED SOLUTION, INC. | Direktor/Vorstandsmitglied | 03.01.2025 |
| OMEROS CORPORATION | Corporate Officer/Principal | 01.05.2017 |
Vactx International, Inc. | Vorstandsvorsitzender | 01.11.2010 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Präsident | 01.12.2007 |
EMulate Therapeutics, Inc.
 EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage health technology company which develops non-invasive therapies for cancers and neuropsychiatric conditions | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Kenneth Ferguson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Health Technology |
Lilly ICOS LLC
 Lilly ICOS LLC Pharmaceuticals: MajorHealth Technology Develops and markets medical drugs | Health Technology |
Omeros Corp.
 Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage health technology company which develops non-invasive therapies for cancers and neuropsychiatric conditions | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyclacel Pharmaceuticals, Inc.
 Cyclacel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes mechanism-targeted drugs to treat human cancers | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Finance |
Texas University of Health Center at San Antonio
 Texas University of Health Center at San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vactx International, Inc. |
